Among the most troubling outcomes of the COVID-19 pandemic has been the thousands of reports of patients living with post-acute sequelae of SARS-CoV-2 infection (PASC) or “long COVID” weeks—even months—after testing positive for the virus.
These patients continue to experience a smattering of persistent symptoms, from fatigue, cognitive dysfunction, and shortness of breath to joint pain, heart inflammation, sleep issues, and more.
What is known about these prolonged health consequences? What does the spectrum of recovery from SARS-CoV-2 infection look like across varying populations? What is the underlying biological cause? Does the COVID-19 vaccine have any effect on these lingering symptoms?
And, perhaps most importantly, how can clinicians help in the management of these patients?
Tune in Wednesday, September 8, 2021, for a live webinar event, co-hosted by the International Society for Vaccines and MJH Life Sciences™, to hear our expert panel talk through these questions and more.
Find out more and register.
